Retinoid X receptors (RXRs) belong to the nuclear receptor superfamily, consisting of a large number of ligand-regulated transcription factors that mediate the diverse physiological functions of their ligands, such as steroid hormones, retinoids, thyroid hormone, and vitamin D 3 , in embryonic development, growth, differentiation, apoptosis, and homeostasis (29, 46) . The superfamily also includes many orphan receptors whose ligands remain to be identified. All nuclear receptors consist of three major domains: the variable length N-terminal domain, the well-conserved DNA-binding domain (DBD), and the ligand-binding domain (LBD) (29, 46) . The C-terminal LBD is multifunctional and, in addition to harboring a ligand-binding site, contains regions for receptor dimerization and the ligand-dependent transactivation function (AF-2). The DBD also contains a dimerization interface that determines target gene specificity (38, 55, 60, 85) . RXRs mediate retinoid signaling through the RXR/retinoic acid receptor (RAR) heterodimer and the RXR/RXR homodimer (29, 46, 89) . In addition, RXRs form heterodimers with many members of the subfamily 1 nuclear receptors, including vitamin D receptor (VDR), peroxisome proliferator-activated receptor (PPAR), and thyroid hormone receptor (TR), as well as several orphan receptors, such as liver X receptor, pregnane X receptor, constitutively activated receptor, and Nur77 (TR3 or NGFI-B) (29, 46) . RXRs, therefore, play an essential role in the regulation of multiple nuclear hormone-signaling pathways through their unique and potent dimerization capacity. The vitamin A metabolite, 9-cis-retinoic acid (9-cis-RA), is a high-affinity ligand for RXRs (22, 39) . It induces transactivation of the RXR homodimer (26, 29, 46, 88, 90) and certain RXR heterodimers, such as the RXR/Nur77 heterodimer (16, 54, 76) .
Heterodimerization of RXR with its partners dramatically enhances their DNA binding and subsequently transcriptional regulation (29, 46, 89) . On binding DNA, some nuclear receptors repress transcription of target genes through their interaction with transcriptional corepressors in the absence of ligands. Ligand binding by a transcriptional agonist causes a conformational change in the receptors, allowing dissociation of transcriptional corepressors and association of transcriptional coactivators (80) . In addition to DNA binding and interaction with receptor cofactors, recent studies suggest that subcellular distribution of RXR and its dimerization partners represents another mechanism that regulates their biological activity. Despite being localized in the nucleus in many cell types, RXR (12, 27) and its partners, including RARs (12) . TRs (2, 6, 92) , VDR (57, 58) , and Nur77 (30, 40) , were found in the cytoplasm in certain cell types and stages during development or under different cellular environments. Interestingly, RXR heterodimerization promotes nuclear localization of TR (2) and VDR (57) .
Orphan receptor Nur77 (7, 20, 51) is an immediate-early response gene whose expression is rapidly induced by a variety of extracellular stimuli, including growth factors, the phorbol ester 12-O-tetradecanoyl-13-phorbol acetate (TPA) and cyclic-AMP-dependent pathways. Nur77 and its closely related family members, Not-1 (also called Nurr1 and RNR-1) (36, 45) and NOR-1 (also called MINOR and TEC) (21, 47, 52) , constitute a distinct subfamily within the nuclear receptor superfamily (29, 46, 48) . Nur77 was originally recognized for its role in cell proliferation and differentiation. Paradoxically, Nur77 was later found to be a potent proapoptotic molecule (48, 73, 84, 86) . The expression of Nur77 was rapidly induced during the apoptosis of immature thymo-cytes and T-cell hybridomas, as well as various types of cancer cells (24, 25, 28, 40, 41, 44, 62, 66, 74, 78) . Overexpression of a dominant-negative Nur77 protein or inhibition of Nur77 expression by antisense Nur77 inhibited apoptosis, whereas constitutive expression of Nur77 resulted in massive apoptosis (40, 41, 44, 66, 69, 74, 75) .
Nur77 can function in the nucleus as a transcription factor to regulate the gene expression necessary to alter the cellular phenotype in response to various stimuli. Consistently, Nur77 response elements (NBRE or NurRE) have been identified (56, 72) . In addition to its heterodimerization with RXR (16, 54) , Nur77 can interact with the orphan receptor COUP-TF (77) that binds to the RAR␤ promoter and is required for efficient RAR␤ expression (42) . Through its interaction with RXR and COUP-TF, Nur77 can modulate RAR␤ expression and the growth response of cells to retinoids (8, 77) . Interestingly, the EWS/TEC (Nor-1) fusion protein generated by the t(9;22) chromosomal translocation in extraskeletal myxoid chondrosarcoma is ϳ270-fold more active than the native receptor in activating a reporter containing the NBRE (34, 35) . This result suggests that the cancer-associated TEC (Nor-1) fusion receptor exerts its oncogenic activity by inducing the expression of target genes involved in cell proliferation. Thus, Nur77 may confer its growth-promoting activities through its action in the nucleus. This is supported by our recent observation that DNA binding and transactivation of Nur77 are required for its induction of cell proliferation (31) .
Recent studies have demonstrated that Nur77 can also act outside the nucleus to mediate several important biological functions, including apoptosis and differentiation. Nur77, in response to apoptotic stimuli, translocates from the nucleus to the cytoplasm where it targets mitochondria to induce cytochrome c release and apoptosis (40) . Our investigation of this phenomenon demonstrated that the proapoptotic effect of Nur77 does not require its transcriptional activity and DNA binding. Furthermore, Nur77 targets mitochondria through its interaction with Bcl-2, resulting in conversion of Bcl-2 from an antiapoptotic to a proapoptotic molecule (43) . Nur77 targets mitochondria in prostate cancer (40, 71) , lung cancer (10, 31) , colon cancer (71) , ovarian cancer (24) , and gastric cancer (28, 79) cells, and its mitochondrial localization is involved in Sindbis virus-induced apoptosis (37) . The cytoplasmic action of Nur77 was also demonstrated by the translocation of NGFI-B from the nucleus to the cytoplasm in response to nerve growth factor (NGF) treatment in PC12 pheochromocytoma cells, suggesting that the cytoplasmic action of NGFI-B is involved in NGF-induced PC12 cell differentiation (30) . Thus, the diverse biological activities of Nur77 depend on its subcellular localization. The importance of TR3 pathways in regulating cancer cell growth is supported by the positive correlation between Nor-1 expression and survival in diffuse large B-cell lymphoma patients on chemotherapy (63) and a recent observation that TR3 is 1 of the 17 signature genes associated with metastasis of primary solid tumors (59) .
Because Nur77 heterodimerizes with RXR␣, we investigated the role of RXR␣ and its ligands in the regulation of the Nur77-dependent apoptotic pathway. Here, we report that RXR␣ migrates from the nucleus to mitochondria as an RXR␣/ Nur77 heterodimer in response to apoptotic stimuli. The migration is mediated by a putative nuclear export sequence (NES) present in the LBD of RXR␣. The RXR␣ NES is active in the RXR␣/Nur77 heterodimer formed through dimerization interfaces in their DBDs. Interestingly, in the presence of RXR␣ ligands, the RXR␣/Nur77 heterodimer is formed through dimerization interfaces in their LBDs. Such an RXR␣ ligand-induced switch of RXR␣/Nur77 heterodimerization interfaces silences the RXR␣ NES. Consistently, RXR␣ ligands effectively inhibit the mitochondrial targeting of the RXR␣/Nur77 heterodimer and apoptosis. Together, our results demonstrate that RXR␣ and its ligands plays a critical role in the regulation of the Nur77-dependent apoptotic pathway through their heterodimerization.
procedure as described previously (42) . For GFP studies, 1 g of GFP or GFP constructs was transfected into cells seeded in six-well plates by calcium phosphate precipitation.
Apoptosis assays. For terminal deoxynucleotidyltransferase (TdT) assays, cells were treated with or without indicated agents overnight after pretreatment with RXR␣ ligand 9-cis-RA or SR11237 for 12 h, treated with trypsin, washed with PBS, fixed in 1% formaldehyde, and then resuspended in 70% ice-cold ethyl alcohol. Cells were then labeled with biotin-16-deocyuridine 5Ј triphosphate by TdT and stained with avidin-fluorescein isothiocyanate (Boehringer Mannheim). For nuclear morphological change analysis, LNCaP cells were treated with trypsin, washed with PBS, fixed with 3.7% paraformaldehyde, and stained with DAPI (4Ј,6Ј-diamidino-2-phenylindole; 50 g/ml) to visualize nuclei by fluorescence microscopy.
Western blotting. Cell lysates were boiled in SDS sample buffer, resolved by SDS-12.5% PAGE, and transferred to nitrocellulose. After transfer, the membranes were blocked in 5% milk in TBST (10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.05% Tween 20) containing antibody. The membranes were then washed three times with TBST and then incubated for 1 h at room temperature in TBST containing horseradish peroxide-linked anti-immunoglobulin. After three washes in TBST, immunoreactive products were detected by using enhanced chemiluminescence (Amersham). Anti-GFP antibody was purchased from Santa Cruz Biotechnology.
RESULTS
RXR␣ targets mitochondria in response to apoptotic stimuli. Nur77 migrates from the nucleus to mitochondria to induce apoptosis in response to certain apoptotic stimuli (10, 24, 31, 37, 40, 43, 71, 78) . Since RXR␣ heterodimerizes with Nur77 (16, 54), we studied whether RXR␣ also targeted mitochondria. Subcellular localization of RXR␣ in LNCaP prostate cancer cells in the absence or presence of TPA, which potently induces LNCaP cell apoptosis (40) , was examined by confocal microscopy analysis. Immunostaining showed that RXR␣ predominantly localized in the nucleus in the absence of TPA treatment (Fig. 1A) . However, when cells were treated with TPA, RXR␣ was found in the cytoplasm. To study whether RXR␣ was associated with mitochondria, cells were stained for heat shock protein 60 (Hsp60), a mitochondrionspecific protein (Fig. 1A) . The extensive overlap in the distribution patterns of Hsp60 and RXR␣ suggested the association of RXR␣ with mitochondria. Similarly, treatment with TPA also resulted in mitochondrial localization of Nur77 (Fig. 1B) , as previously reported (40) . The enhanced staining of Nur77 in TPA-treated cells was due to induction of endogenous Nur77 expression by TPA. Thus, RXR␣ and Nur77 associate with mitochondria in LNCaP cells undergoing apoptosis.
RXR␣ and Nur77 mitochondrial targeting are mutually dependent. To study whether Nur77 and RXR␣ targeted mitochondria as a heterodimer, subcellular localization of Nur77 and RXR␣ was examined in LNCaP cells treated with or without TPA. In the absence of TPA, both Nur77 and RXR␣ resided mainly in the nucleus (Fig. 1C) . However, when cells were treated with TPA, Nur77 and RXR␣ were colocalized in the cytoplasm and their distribution patterns overlaid extensively (Fig. 1C) , suggesting their association in the cytoplasm. We also examined whether transfected RXR␣ and Nur77 targeted mitochondria in response to apoptosis induction. When expression vectors for RXR␣ and Nur77 were transfected into LNCaP cells, the expressed RXR␣ and Nur77 resided in the nucleus. However, when cells were treated with 3-Cl-AHPC, a apoptosis-inducing retinoid (91) , both RXR␣ and Nur77 were found in the cytoplasm, and their distributions were overlaid (Fig. 1D) . It is noteworthy that we have consistently observed that endogenous RXR␣ and Nur77 targeted mitochondria VOL. 24, 2004 REGULATION OF Nur77 APOPTOTIC PATHWAY BY RXR␣ 9707 FIG. 1. Nur77 and RXR comigrate from the nucleus to the cytoplasm. (A/B) RXR␣ (A) or Nur77 (B) targets mitochondria in response to apoptotic stimulus. LNCaP prostate cancer cells were treated with TPA (100 ng/ml) for 1 h and then immunostained with either anti-RXR␣ (Santa Cruz Biotechnology) (A) or anti-Nur77 (Active Motif) (B) antibody, followed by Cy3-conjugated secondary antibody (Sigma) to detect RXR␣ or Nur77 or with anti-Hsp60 (Santa Cruz Biotechnology), followed by FITC-conjugated secondary antibody (Sigma) to detect mitochondria. RXR␣, Nur77, and mitochondria (Hsp60) were visualized by using confocal microscopy, and the images of RXR␣ or Nur77 with those of mitochondria were overlaid (overlay). About 80% of cells displayed mitochondrial targeting of RXR␣ and Nur77 when cells were treated with TPA. One of three similar experiments is shown. (C) Nur77 and RXR␣ comigrate from the nucleus to the cytoplasm. LNCaP cells were treated with or without TPA for 1 h and then immunostained with anti-RXR␣ antibody, followed by FITC-conjugated secondary antibody, or with anti-Nur77 antibody (Abgent, San Diego, Calif.), followed by Cy3-conjugated secondary antibody. RXR␣ and Nur77 were visualized by using confocal microscopy and the images were overlaid (overlay). Approximately 80% of TPA-treated cells showed RXR␣ colocalization with Nur77. One of three similar experiments is shown. (D) 3-Cl-AHPC induces mitochondrial localization of transfected RXR␣ and Nur77. Expression vectors for myc-Nur77 and RXR␣ were with much higher efficiency than the transfected receptors, suggesting the possible involvement of other protein factors in their targeting. We next determined whether RXR␣ cytoplasmic localization depended on Nur77 expression by examining its subcellular localization in LNCaP cells stably expressing Nur77 antisense RNA (40) . Expression of Nur77 antisense RNA strongly inhibited TPA-induced Nur77 expression in LNCaP cells (40) . In contrast to that observed in wild-type LNCaP cells (Fig. 1A) , RXR␣ was found only in the nucleus in the Nur77 antisense stable clone, even though the cells were treated with TPA (Fig. 1E) . To study whether Nur77 mitochondrial targeting required RXR␣, we used the siRNA approach (14) to inhibit RXR␣ expression in LNCaP cells and then examined the subcellular localization of Nur77. Transfection of LNCaP cells with RXR␣ siRNA strongly reduced RXR␣ protein levels (Fig. 1F) . In cells transfected with RXR␣ siRNA, Nur77 was mainly confined in the nucleus despite TPA treatment (Fig. 1F) . Thus, cytoplasmic localization of Nur77 and RXR␣ is mutually dependent. We previously reported that Nur77 with its N terminus deleted (Nur77/⌬1) acted as a dominant-negative mutant, which inhibited Nur77 mitochondrial targeting and apoptosis (40) . Therefore, we examined whether Nur77/⌬1 also interfered with RXR␣ mitochondrial targeting. GFP-Nur77/⌬1 was transfected into LNCaP cells, which were then treated with TPA. RXR␣ immunostaining showed that RXR␣ was confined to the nucleus in cells transfected with GFP-Nur77/⌬1 in the absence or presence of TPA treatment (Fig. 1G) . Thus, Nur77/⌬1 retained RXR␣ in the nucleus probably through their heterodimerization, and the Nur77 N-terminal sequences are important for the TPA effect. It is noteworthy that the N terminus of Nur77 is enriched with serine, threonine, and tyrosine residues, suggesting the potential regulation of Nur77 activity by phosphorylation. To determine whether mitochondrial targeting of RXR␣ and Nur77 was specific to LNCaP cells and to the TPA treatment, we treated H460 lung cancer cells with 3-Cl-AHPC, which potently induced the apoptosis of lung cancer cells (31) . Similar to what we observed with the LNCaP cells, the treatment of H460 cells with 3-Cl-AHPC resulted in extensive targeting of RXR␣ and Nur77 to mitochondria (Fig. 1H) .
To further characterize the mitochondrial targeting of RXR␣ and Nur77, we conducted a time course analysis of their targeting in LNCaP cells treated with TPA ( Fig. 2A) . Immunoblotting of mitochondrion-enriched HM fractions showed that both RXR␣ and Nur77 began to be associated with mitochondria as early as 1 h after cells were treated with the apoptotic stimulus. This result is consistent with our previous observation showing that Nur77 targeted mitochondria after LNCaP cells were treated with TPA for 1 h (40). The simultaneous targeting of RXR␣ and Nur77 to mitochondria again suggested that they targeted mitochondria as a heterodimer. We previously reported that mitochondrial targeting of Nur77 initiated the release of cytochrome c from mitochondria (40) . Consistently, we observed significant amounts of cytochrome c in the cytosolic fractions after LNCaP cells were treated with TPA for 1.5 h. These results indicate that mitochondrial targeting of RXR␣ and Nur77 precedes the release of cytochrome c, further demonstrating the role of Nur77/RXR␣ mitochondrial targeting in triggering cytochrome c release. The requirement of RXR␣ in Nur77-dependent apoptosis is also illustrated by our observation that inhibition of RXR␣ expression by the expression of RXR␣ siRNA diminished the apoptotic effect of TPA in LNCaP cells (Fig. 2B) . Similar results were also obtained in H460 lung cancer cells treated with 3-Cl-AHPC (Fig. 2C ). Subcellular localization of RXR␣ and Nur77 mutants. Previous studies showed that the cytoplasmic localization of NGFI-B and RXR was mediated through a CRM1-dependent nuclear export process (30) . To study whether the translocation of the RXR␣/Nur77 heterodimer from the nucleus to the cytoplasm is mediated through this process, we examined the effect of leptomycin B (LMB), an inhibitor of CRM1-dependent nuclear export (33) . Treatment of LNCaP cells with LMB completely blocked TPA-induced cytoplasmic localization of both Nur77 and RXR␣ (Fig. 3A) . This result suggests that the nuclear export of the RXR␣/Nur77 heterodimer during apoptosis is mediated by a CRM1-dependent mechanism, a finding similar to that observed for the RXR/NGFI-B heterodimer (30) . To identify the putative NES responsible for the nuclear export of RXR␣/Nur77 heterodimer, various Nur77 and RXR␣ mutants were constructed (Fig. 3B ) and fused to GFP. The fusions were then transfected into HEK293T cells, and their cellular localization was examined by confocal microstransfected into LNCaP cells. Cells were then treated with 3-Cl-AHPC for 3 h and then immunostained with anti-myc antibody (9E10; Santa Cruz Biotechnology), followed by FITC-conjugated secondary antibody, anti-RXR␣ antibody, followed by Cy3-conjugated secondary antibody or anti-Hsp60 antibody, followed by Cy5-conjugated secondary antibody (Jackson Immunoresearch). Myc-Nur77, RXR␣, and Hsp60 were visualized and the images were overlaid. Overlay 1 is the merger of myc-Nur77 and RXR␣ images, and overlay 2 is the merger of myc-Nur77, RXR␣, and Hsp60 images. About 30% of transfected cells exhibited the colocalization presented. One of three similar experiments is shown. (E) Mitochondrial localization of RXR␣ is Nur77 dependent. LNCaP cells or LNCaP cells stably expressing Nur77 antisense RNA (Nur77/antisense) (40) were treated with or without TPA for 1 h and then immunostained with anti-RXR␣ antibody, followed by Cy3-conjugated secondary antibody. Approximately 70% of cells displayed the effect presented. One of two similar experiments is shown. (F) Effect of RXR siRNA on RXR␣ levels and Nur77 localization. LNCaP cells were transfected with or without RXR␣ siRNA or control siRNA for 72 h. Cell extracts were prepared and analyzed for RXR␣ expression by Western blotting. Cells were also analyzed for subcellular localization of RXR␣ and Nur77 by confocal microscopy. One of two similar experiments is shown. (G) Nur77/⌬1 prevents RXR␣ mitochondrial targeting. LNCaP cells were transfected with the GFP-Nur77/⌬1 expression vector and then treated with TPA for 1 h and immunostained with anti-RXR␣ antibody. RXR␣ and GFP-Nur77/⌬1 distributions were analyzed by confocal microscopy. About 80% of nontransfected cells showed cytoplasmic localization of RXR␣ after treatment with TPA, whereas Ͼ70% of cells transfected with GFP-Nur77/⌬1 showed RXR␣ nuclear localization with the same treatment. One of three similar experiments is shown. (H) 3-Cl-AHPC induces mitochondrial localization of RXR␣ and Nur77 in H460 lung cancer cells. H460 cells were treated with 3-Cl-AHPC (10 Ϫ6 M) for 3 h and then immunostained with anti-RXR␣ antibody, followed by FITC-conjugated secondary antibody, anti-Nur77 followed by Cy3-conjugated secondary antibody, or anti-Hsp60 antibody, followed by Cy5-conjugated secondary antibody (Jackson Immunoresearch). RXR␣, Nur77, and Hsp60 were visualized by confocal microscopy, and the images were overlaid. Overlay 1 represents the merger of RXR␣ and Nur77 images. Overlay 2 indicates merged RXR␣, Nur77, and Hsp60 images. Approximately 80% of 3-Cl-AHPC-treated cells showed the patterns presented. One of three similar experiments is shown. 3C ). HEK293T cells were used for these studies because of their high transfection efficiency. GFP was equally distributed in both the nucleus and the cytoplasm of HEK293T cells, indicating the absence of a nuclear localization signal (NLS) and NES. GFP-Nur77 and GFP-RXR␣, however, were found predominantly in the nucleus. The RXR␣ and Nur77 mutants with only the A/B domain, RXR␣/135 and Nur77/170 were diffusely distributed in both the nucleus and cytoplasm. However, mutants that contain the A/B, C, and D domains and a portion of the E domain-RXR␣/235, RXR␣/347, Nur77/ 467, and Nur77/410-were confined to the nucleus, with the exception of RXR␣/385 (see below). The nuclear localization of these mutants may reflect the presence of an NLS in the DBD of the receptors (11) . Indeed, an NLS was identified in the DBD of RXR␣ (57) . Consistently, deletion of the DBD from Nur77 resulted in a mutant (Nur77/⌬DBD) that exclusively localized in the cytoplasm. Interestingly, C-terminus mutants of RXR␣ or Nur77-RXR␣/C1, RXR␣/C2, RXR␣/ C3, Nur77/⌬C2, and Nur77/⌬C3-were found predominantly in the cytoplasm.
Identification of a putative NES in RXR␣.
A previous study (30) demonstrated that the C-terminal half of Nur77 contains several NES sequences. To determine whether the cytoplasmic localization of the RXR␣ C-terminal-domain mutants was mediated by a CRM1-dependent mechanism, the effect of LMB on their cellular localization was examined ( Cells were treated with TPA (100 ng/ml) for the indicated times. Mitochondrion-enriched HM and cytosolic fractions were prepared and analyzed for the presence of RXR␣, Nur77, and cytochrome c as indicated. As a control, the whole-cell extract was also analyzed. Expression of mitochondrion-specific Hsp60 protein and nucleus-specific PARP protein was determined to control the purity of HM fractions. One of two similar experiments is shown. (B) Inhibition of RXR␣ expression suppresses the apoptotic effect of TPA. LNCaP cells were transfected with RXR␣ siRNA, followed by treatment with TPA (100 ng/ml) for 3 h. Cells were stained with DAPI and analyzed for nuclear morphological changes. Apoptotic cells were scored by examining 300 cells for apoptotic morphology from three different experiments. (C) Time course analysis of H460 cells in response to 3-Cl-AHPC. Cells were treated with 3-Cl-AHPC (10 Ϫ6 M) and analyzed as described for panel A. One of two similar experiments is shown.
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FIG. 3. Identification of domains in RXR␣ and
Nur77 required for their nuclear export. (A) Cytoplasmic localization of RXR␣/Nur77 is mediated by CRM1-dependent nuclear export. LNCaP cells were treated with TPA (100 ng/ml) in the absence (control) or presence of LMB (2.5 ng/ml; Sigma) and analyzed by confocal microscopy as described for Fig. 1C . About 80% cells showed the cytoplasmic localization of RXR␣ and Nur77 after treatment with TPA, whereas Ͼ50% of cells showed nuclear localization of RXR␣ and Nur77 when pretreated with LMB. One of two similar experiments is shown. (B) Schematic representations of RXR␣ and Nur77 mutants. The DBD, LBD, and A to F domains are indicated. (C) Analysis of subcellular localization of Nur77 and RXR␣ mutants. The indicated plasmids were transfected into HEK293T cells and analyzed by confocal microscopy as described in Fig. 1 . More than 90% of transfected cells showed diffused distribution of GFP and GFP-RXR␣/135. Nuclear localization of GFP-RXR␣, RXR␣/235, and RXR␣/347 was found in 80, 85, and 60% of transfected cells, respectively. More than 90% of transfected cells showed exclusive cytoplasmic localization of RXR␣/385, RXR␣/C2, and RXR␣/C3, whereas cytoplasmic localization of RXR␣/C1 was found in 70% of transfected cells. Nuclear localization of GFP-Nur77 and its mutants, GFP-Nur77/⌬2, GFP-Nur77/⌬1, GFP-Nur77/467, and GFP-Nur77/410, was found in Ͼ90% of transfected cells, whereas cytoplasmic localization of GFP-Nur77/⌬DBD, cytoplasmic localization of GFP-Nur77/⌬DBD, GFP-Nur77/⌬C2, and GFP-Nur77/⌬C3 was observed in 80, 60 and 70% of transfected cells, respectively. One of four similar experiments is shown. which is consistent with our confocal microscopy results (Fig.  3C ), GFP-RXR␣/C3 was only found in the cytoplasm (Fig.  4B) . The exclusive cytoplasmic presence of GFP-RXR␣/C3 was prevented when cells were treated with LMB (Fig. 4C) .
Our results are consistent with a previous observation that mutation of the RXR␣ NLS resulted in its predominant cytoplasmic localization (57) and suggest that RXR␣/C3 contains an active NES. The CRM1-dependent nuclear export is mediated by a Leurich NES (70) . Inspection of RXR/C3 revealed the presence of a methionine-rich sequence, which had significant homology to previously identified NESs (Fig. 4D) . To determine whether the RXR␣ sequence represented a putative NES, the DNA sequence representing the RXR␣ amino acids 348 to 368 was fused to GFP. The resulting GFP fusion, GFP-NES, was transfected into HEK293T cells. As shown in Fig. 4E , the GFP-NES protein was found exclusively in the cytoplasm, whereas the fusion was diffusely distributed in cells in the presence of LMB. Furthermore, replacing Met357 and Met360 in the NES with Ala ( Fig. 4D ) largely abolished its nuclear export activity (Fig.  4E) . Thus, the RXR␣ amino acid 348 to 368 sequence represents a putative NES. This conclusion is also supported by our observation that GFP-RXR␣/385 was exclusively localized in the cytoplasm, whereas the removal of amino acid residues 348 to 385 from the mutant abolished its cytoplasmic localization, as indicated by the nuclear localization of GFP-RXR␣/347 (Fig. 3C) . To determine the role of the RXR␣ NES in mediating the nuclear export of Nur77 and RXR␣, both Met357 and Met360 in full-length RXR␣ were replaced with Ala. The resulting mutant, RXR␣/NESm, was cotransfected with Nur77 into LNCaP cells. Unlike RXR␣ and Nur77, which targeted mitochondria in response to 3-Cl-AHPC treatment (Fig. 1D) , both RXR␣/NESm and Nur77 remained in the nucleus despite 3-Cl-AHPC treatment (Fig. 4F) . Thus, the RXR␣ NES is required for apoptosis-induced nuclear export of the RXR␣/ Nur77 heterodimer.
Our observation that RXR␣/385 was exclusively confined to the cytoplasm even in the absence of an apoptotic stimulus (Fig. 3C ) was intriguing since this mutant contains both the NLS and NES. This result suggests that removal of the Cterminal sequences (amino acid residues 386 to 462) strongly activates the RXR␣ NES and/or silences its NLS. To determine whether the superactivation of RXR␣ NES in RXR␣/385 could confer cytoplasmic localization to Nur77, RXR␣/385 was cotransfected into HEK293T cells with Nur77 or its mutant Nur77/⌬1 or Nur77/467, all of which alone resided in the nucleus (Fig. 3C) . Our data showed that coexpression of RXR␣/ 385 with Nur77 or either mutant resulted in their colocalization in the cytoplasm (Fig. 4G) . The extensive colocalization of RXR␣/385 with Nur77, Nur77/467, or Nur77/⌬1 suggests that they comigrated to the cytoplasm as a heterodimer. Thus, RXR␣/385 was able to shuttle Nur77 to the cytoplasm. In contrast, Nur77/⌬C3 could not confer its cytoplasmic localization to RXR␣ when they were coexpressed (Fig. 4G) . Thus, the RXR␣ NES plays a critical role in the nuclear export of the RXR␣/Nur77 heterodimer.
Role of Bcl-2 in RXR␣ mitochondrial targeting. We recently reported that TR3 mitochondrial targeting requires its interaction with Bcl-2 (43). Therefore, we examined whether Bcl-2 expression modulated RXR␣ mitochondrial targeting. GFP-RXR␣/385 was cotransfected with Bcl-2, and their distribution patterns were visualized by confocal microscopy. Figure 5A shows that expression of Bcl-2 did not alter the diffuse distribution of GFP-RXR␣/385. However, when Nur77 was cotransfected, GFP-RXR␣/385 colocalized with both Nur77 and Bcl-2, as evidenced by punctate staining. This result indicated that Bcl-2 interacted with Nur77 but not RXR␣. The requirement of Nur77 and Bcl-2 for RXR mitochondrial targeting was also illustrated by our cellular fractionation assay (Fig. 5B) . GFP-RXR␣/385 expressed in HEK293T cells did not show any accumulation in the mitochondrion-enriched HM fraction in the absence or presence of Bcl-2 coexpression. However, when Nur77/⌬2, a Nur77 mutant lacking the N-terminal 122 amino acid residues, was coexpressed, a significant amount of GFP-RXR␣/385 was found in the HM fraction, whereas its cytosolic level decreased (Fig. 5B) . Together, these results demonstrate that mitochondrial targeting of RXR␣ requires both Nur77 and Bcl-2 and that the RXR␣/Nur77 heterodimer interacts with Bcl-2.
Mitochondrial targeting and apoptotic effect of RXR␣ and Nur77 mutants. To study the role of cytoplasmic mutants of Nur77 and RXR␣ in apoptosis, GFP-RXR␣/C1, GFP-RXR␣/ 385, GFP-Nur77/⌬C3, and GFP-Nur77/⌬DBD were transfected into LNCaP cells. Cells were then analyzed for nuclear morphological changes by DAPI staining (Fig. 6A) . Interestingly, cells transfected with the Nur77 mutants exhibited extensive nuclear fragmentation and condensation, which are characteristics of apoptotic cells. In contrast, cells transfected with the RXR␣ mutants displayed normal nuclear morphology. Consistently, expression of Nur77/⌬DBD in LNCaP cells targeted mitochondria and triggered extensive cytochrome c release, while expression of RXR/C1 did not (Fig. 6B) . The mitochondrial targeting of Nur77/⌬DBD in LNCaP cells but not in HEK293T cells likely reflects the expression of Bcl-2 in LNCaP cells but not in HEK293T cells (43) . Thus, the cyto-NES (RVLTELVSKMRDMQMDKTELG) or its mutant (RVLTELVSKARDAQMDKTELG) (NESm) was fused to GFP, and the expression vectors were transfected into HEK293T cells. Cells were treated with or without LMB for 6 h and then stained for Hsp60 and analyzed by confocal microscopy. Approximately 90% of GFP-NES-transfected cells exhibited cytoplasmic localization, whereas Ͻ20% of GFP-NESm-transfected cells displayed the same cytoplasmic localization. One of three similar experiments is shown. (F) Mutation of the RXR␣ NES impairs the 3-Cl-AHPCinduced mitochondrial localization of RXR␣/Nur77 heterodimer. Myc-Nur77 was cotransfected with RXR␣/NESm into LNCaP cells, which were then treated with 3-Cl-AHPC (10 Ϫ6 M) for 3 h. Cells were stained for Nur77 by anti-myc antibody and for RXR␣/NESm by anti-RXR␣ antibody and analyzed by the confocal microscopy. About 90% of transfected cells showed nuclear localization of Myc-Nur77 and RXR␣/NESm, even after treatment with 3-Cl-AHPC. (G) RXR␣ NES is required for cytoplasmic localization of Nur77. The indicated expression vectors were cotransfected into HEK293T cells. Their subcellular localization was analyzed by confocal microscopy as described in Fig. 1A . Less than 10% of transfected cells showed cytoplasmic localization of GFP-Nur77, Nur77/467, and Nur77/⌬1, which was increased to 30, 40, and 40% upon cotransfection with Flag-RXR␣/385, respectively. About 80% of transfected cells showed nuclear localization of Flag-RXR␣, with or without Nur77/⌬C3 cotransfection. One of three similar experiments is shown. (Fig. 7A) . The inhibitory effect of the RXR ligands on the cytoplasmic accumulation of RXR␣/C1 was confirmed by immunoblotting analysis (Fig. 7B) , which showed an equal distribution of GFP-RXR␣/C1 in both cytoplasmic and nuclear fractions after cells were treated with 9-cis-RA or SR11237 but not with RAR␣ ligand Am80. In contrast, GFP-RXR␣/C1 was only found in the cytoplasm in nontreated cells.
We next examined the cellular distribution of GFP-RXR␣/ C1 expressed in HEK293T cells in the absence or presence of 9-cis-RA by nondenaturing PAGE. As shown in Fig. 7C , GFP-RXR␣/C1 was found only as a monomer in the cytoplasmic fraction. After cells were treated with 9-cis-RA, the monomeric form of GFP-RXR␣/C1 in the cytoplasmic fraction dis- Expression vectors of GFP-RXR␣/385 and Bcl-2 were transfected, together with or without myc-Nur77 vector into HEK293T cells. Cells were then immunostained with anti-myc antibody (9E10; Santa Cruz Biotechnology), followed by Cy3-conjugated secondary antibody, or with anti-Bcl-2 antibody, followed by Cy5-conjugated secondary antibody. GFP-RXR␣/385, myc-Nur77, and Bcl-2 were visualized by confocal microscopy. Overlay 1 represents the merger of the GFP-RXR␣/385 and myc-Nur77 images, and overlay 2 is a merge of the GFP-RXR␣/385, myc-Nur77, and Bcl-2 images. Approximately 70% of cells transfected with GFP-RXR␣/385 and myc-Nur77 exhibited colocalization with Bcl-2, whereas Ͻ5% of cells transfected with GFP-RXR␣/385 alone showed colocalization with Bcl-2. (B) Accumulation of RXR␣/385 at mitochondria in HEK293T cells requires both Nur77 and Bcl-2. Flag-RXR␣/385, GFP-Nur77/⌬2, and Bcl-2 were transfected into HEK293T cells as indicated. HM and cytosolic fractions were prepared and levels of Flag-RXR␣/385, GFP-Nur77/⌬2, and Bcl-2 were determined by immunoblotting with anti-Flag (Sigma), anti-GFP, and anti-Bcl-2 antibody, respectively. For control, levels of Hsp60 and PARP were also determined. One of two similar experiments is shown.
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appeared, and only the homodimeric form was detected in the nuclear fraction. These studies demonstrate that monomeric RXR␣ exists in the cytoplasm, whereas liganded-homodimeric RXR␣ is in the nucleus. Thus, the RXR ligands 9-cis-RA and SR11237 inhibit RXR␣ nuclear export probably by inducing RXR␣ homodimerization. We also analyzed the subcellular localization of two RXR␣ mutants: RXR␣/385, which lacks the major homodimerization domain, and RXR␣/LLL, which has Leu418, Leu420, and Leu430 in helix 10 replaced with Ala and fails to homodimerize in response to 9-cis-RA (90). Interestingly, both homodimerization-defective RXR␣ mutants were exclusively localized in the cytoplasm regardless of the presence of 9-cis-RA (Fig. 7D) . We also used another RXR␣ mutant, RXR␣/C1/C432R, to study the role of ligand in the regulation of RXR␣ subcellular localization. Cys432 is involved in the formation of the RXR␣ ligand-binding pocket and primarily responsible for the shorter length of this L-shaped pocket compared to the linear RAR I-shaped pocket (13) . Replacing Cys432 with Arg (RXR␣/C1/C432R) impaired homodimerization in response to 9-cis-RA (data not shown). RXR/C1/ C432R expressed in HEK293T cells was stained exclusively in the cytoplasm despite 9-cis-RA treatment (Fig. 7D) . Together, (A) GFP-RXR␣/C1 was transfected into HEK293T cells, which were then treated with the indicated retinoid, stained with Hsp60, and analyzed by confocal microscopy. The inhibitory effect of RXR ligands on the cytoplasmic localization of RXR␣/C1 was observed in 80% of transfected cells, whereas Ͼ90% of transfected cells failed to respond to RAR ligands. (B) Nuclear and cytoplasmic extracts were also prepared and analyzed for expression of GFP-RXR␣/C1 by Western blotting with anti-GFP antibody. One of three similar experiments is shown. (C) RXR␣/C1 dimerization status determines its subcellular localization. GFP-RXR␣/C1 was transfected into HEK293T cells, which were not treated or treated with 9-cis-RA (10 Ϫ7 M). Nuclear and cytoplasmic extracts were prepared and analyzed by using nondenaturing PAGE and anti-GFP antibody. The same extracts were analyzed by denaturing PAGE for the expression of PARP and Hsp60 to ensure fraction purity. One of two similar experiments is shown. (D) Confocal microscopy analysis of RXR homodimerization-defective mutants. GFP-RXR␣/385, GFP-RXR␣/LLL, or GFP-RXR␣/C1/C432R was transfected into HEK293T cells. Cells were treated with or without 9-cis-RA (10 Ϫ7 M) and analyzed by confocal microscopy. Approximately 80% of transfected cells showed nuclear localization of GFP-RXR␣, which was slightly increased to 85% after treatment with 9-cis-RA. Cytoplasmic localization of GFP-RXR␣/385 (90%), GFP-RXR␣/LLL (65%), and GFP-RXR␣/C1/C432R (85%) was not affected by 9-cis-RA treatment. One of three similar experiments is shown. (29, 46, 89) . Therefore, we analyzed the subcellular localization of RXR␣/VDR and RXR␣/RAR heterodimers. GFP-RXR␣ was transfected alone or with either VDR (Fig. 8A) or RAR␣ (Fig. 8B) into HEK293T cells. Without cotransfection, GFP-RXR␣ was distributed in both the cytoplasm and the nucleus. However, on cotransfection of VDR or RAR␣, the cytoplasmic localization of GFP-RXR␣ was completely abolished and the levels of nuclear GFP-RXR␣ increased. Treatment of cells with the VDR ligand 1␣,25-dihydroxyvitamin D 3 or the RAR ligand trans-RA did not further modulate the cellular distribution of cotransfected GFP-RXR␣. The inhibitory effect of VDR was also examined by studying the subcellular localization of RXR␣/C1 in the absence or presence of VDR coexpression. In the absence of VDR, RXR␣/C1 exclusively localized in the cytoplasm of HEK293T cells. However, when VDR was cotransfected, RXR␣/C1 was confined to the nucleus and its distribution pattern overlaid with that of VDR. Again, addition of 1␣,25-dihydroxyvitamin D 3 had no effect on localization of both VDR and RXR␣/C1 (Fig. 8C) . Together, these results demonstrate that heterodimerization of RXR␣ with RAR and VDR suppresses RXR␣ NES activity in a ligand-independent manner.
Unique RXR␣ heterodimerization with Nur77. The data presented above demonstrate that RXR␣ NES activity was suppressed upon RXR␣ homodimerization and RXR␣ heterodimerization with VDR and RAR. Ironically, RXR␣ was required for the cytoplasmic localization of Nur77 through their heterodimerization. One possible explanation is that the RXR␣/Nur77 heterodimer may be different from other RXR␣ heterodimers. Three types of RXR heterodimers have been described (29, 46) . In some heterodimers, such as the RXR/ VDR, RXR is a completely silent partner. In others, such as the RXR/RAR, RXR is a conditionally silent partner. In contrast, RXR acts as a fully active and competent partner of heterodimers with certain orphan receptors, such as Nur77 (16, 54) . Heterodimerization of RXR␣ with RAR␣ in solution largely depends on their dimerization interfaces localized in their LBDs and has been mapped to a region in the carboxyl terminus, corresponding to helices 9 and 10 in the canonical nuclear receptor LBD structure (5, 13, 17, 18) . The results of studies on RXR/Nur77 heterodimerization that indicated different interaction modalities depending on systems and approaches (1, 61, 68) suggest that RXR and Nur77 may interact differently under different conditions. Our finding that RXR␣/ 385 was able to shuttle Nur77/467 from the nucleus to the (Fig. 4G) suggests that RXR␣ may utilize regions other than the LBD C terminus for binding Nur77. This possibility was studied by using GST pull-down assays. Full-length RXR␣ was pulled down by either GST-Nur77 or GST-RAR␣ (Fig. 9A) , whereas RXR␣/385 was only pulled down by GSTNur77 but not by GST-RAR␣. Thus, in solution the RXR␣ C terminus is required for its interaction with RAR␣ but not with Nur77. Similarly, as Nur77/467 was effectively pulled down by GST-RXR␣ (Fig. 9B) , the Nur77 C terminus was also dispensable for interaction with RXR␣ in solution. The interaction between RXR␣/385 and Nur77 was also revealed by in vivo coimmunoprecipitation, which showed the efficient precipitation of GFP-RXR␣/385 by anti-Flag antibody when Flag-Nur77 was coexpressed in HEK293T cells (Fig. 9C ). In the reporter gene assays, both RXR␣/385 and RXR␣ similarly inhibited the transactivation of Nur77 homodimer activity in the absence of 9-cis-RA (Fig. 9D) . The addition of 9-cis-RA slightly enhanced the inhibitory effect of RXR␣ but not RXR␣/385. The RXR␣ DBD also contains a dimerization interface (38, 55, 60, 85) . To determine whether the dimerization interfaces in the DBDs of RXR␣ and Nur77 are involved in their heterodimerization in solution, several RXR␣ and Nur77 mutants were constructed ( Fig. 9E ) and their interaction was analyzed. The RXR␣ DBD alone (RXR␣/135-200) was as efficient as the whole-length RXR␣ in pulling down Nur77/467. Removal of the C-terminal portion from the RXR␣ DBD completely abolished its interaction with Nur77/467 (Fig. 9F) . Similarly, Nur77 deleted with the D-E/F domains (Nur77/332) retained the ability to bind RXR␣, whereas further deletion of the C-terminal portion from the Nur77 DBD completely abolished its ability to bind RXR␣. Together, these results demonstrate that the dimerization interfaces in the DBDs of RXR␣ and Nur77 are mainly responsible for their interaction in solution.
Modulation of RXR␣/Nur77 heterodimerization by RXR ligands. The RXR/Nur77 heterodimer binds and activates DNA sequences consisting of AGGTCA or like motifs arranged as a direct repeat with a 5-bp spacing (the DR-5 response element) (16, 54, 76) . To characterize RXR␣/Nur77 heterodimerization on DNA, gel shift assays were conducted by using the ␤RARE, a DR-5 element, as a probe (Fig. 10A) . In vitro-synthesized Nur77 and RXR␣ bound to the ␤RARE as a heterodimer (Fig.  10A) , as reported previously (76, 77) . However, when Nur77/ 467, which heterodimerizes with RXR␣ in solution (Fig. 9B) , was incubated with RXR␣, we did not detect any heterodimeric complex binding to the ␤RARE (Fig. 10A) . Similarly, coincubation of RXR␣/385 and Nur77 did not result in formation of a stable heterodimer on the ␤RARE (Fig. 10A) . Thus, the C termini of both Nur77 and RXR␣ are required for the formation of a stable RXR␣/Nur77 heterodimer complex on the ␤RARE. This finding is also supported by our analysis of Nur77 mutants for their transactivation activity on the NurRE and ␤RARE (Fig. 10B) . Removal of the Nur77 C terminus did not affect its transactivation on NurRE as Nur77 and Nur77/ 467 similarly activated the NurRE (Fig. 10B) . These results are consistent with recent reports that the major transactivation function of Nur77 is located in its N terminus (68) . In contrast, Nur77/467 failed to activate the ␤RARE on cotransfection with RXR␣ in either the absence or presence of RXR ligand SR11237, whereas cotransfection of full-length Nur77 and RXR␣ strongly activated the ␤RARE in response to SR11237 (Fig. 10B) . The lack of transactivation activity displayed by Nur77/467 is likely a reflection of its inability to form ␤RARE-bound heterodimers with RXR␣ (Fig. 10A) .
To determine how RXR ligands influenced RXR␣/Nur77 heterodimer binding to the ␤RARE, RXR␣ protein was exposed to its ligand SR11237 or 9-cis-RA prior to incubation with Nur77. Although the RXR␣/Nur77 heterodimer bound to the ␤RARE in the absence of an RXR ligand, the addition of SR11237 or 9-cis-RA strongly enhanced binding by the heterodimer (Fig. 10C) . These data suggest that RXR␣/Nur77 heterodimers in solution may be incompetent for DNA binding and that RXR ligand binding may induce a C-terminal-stabilized heterodimer conformation that favors DNA binding. To address the possibility that an RXR ligand can modulate the RXR␣/Nur77 heterodimerization interface, we used GST pulldown assays to study the effect of 9-cis-RA on the interaction between Nur77/467 and RXR␣ (Fig. 10D) . Incubation of GST-RXR␣ with 9-cis-RA strongly reduced the ability of GST-RXR␣ to interact with Nur77/467, suggesting that 9-cis-RA binding may mask or alter a putative dimerization interface required for RXR␣ binding to Nur77 in solution. In comparison, the addition of 9-cis-RA did not affect the binding of RXR␣/385 to GST-Nur77. Thus, the dimerization interface for the formation of the RXR␣/Nur77 heterodimer in solution is different from that required for the formation of the DNAbound heterodimer and is regulated by RXR ligand binding.
RXR␣ mitochondrial localization is inhibited by RXR␣ ligands. Inhibition of RXR␣ mitochondrial localization by its ligands was demonstrated by immunoblotting HM fractions from LNCaP cells. The accumulation of RXR␣ in the HM fraction after cells were treated with TPA or an analog of AHPN/CD437 (SR11453) (40) was inhibited by pretreatment with 9-cis-RA (Fig. 11A) . Similar to its effect on RXR␣, mitochondrial accumulation of Nur77 was also abolished by 9-cis-RA pretreatment (Fig. 11A) . The observation that 9-cis-RA inhibited Nur77 mitochondrial targeting further suggests the role of RXR␣ in the regulation of Nur77 mitochondrial targeting.
Since RXR␣ comigrated with Nur77 from the nucleus to mitochondria in cells undergoing apoptosis, we investigated the effect of 9-cis-RA on cytochrome c release and apoptosis. lease of cytochrome c from mitochondria, as revealed by cytochrome c staining, which was diffusely distributed (Fig. 11B) . However, on pretreatment with 9-cis-RA, cytochrome c staining was only detected in the mitochondria, since its distribution colocalized with that of Hsp60. LNCaP cells were also transfected with GFP-Nur77 to monitor the effect of 9-cis-RA on Nur77 mitochondrial targeting (Fig. 11B) . TPA-induced cytochrome c release was accompanied with the mitochondrial localization of transfected GFP-Nur77. However, when cells were pretreated with 9-cis-RA, GFP-Nur77 was confined in the nucleus and cytochrome c release was inhibited (Fig. 11B) . These data further demonstrate the role of Nur77 mitochondrial targeting in the induction of cytochrome c release and the inhibitory effect of RXR ligands on Nur77-dependent apoptosis. The inhibition of cytochrome c release by 9-cis-RA was further revealed by immunoblotting of cytosolic fractions prepared from LNCaP cells treated with TPA or the AHPN analog SR11453 (Fig. 11C) . In the absence of 9-cis-RA, significant cytoplasmic cytochrome c was detected in treated cells, whereas preexposure of cells to 9-cis-RA prevented cytochrome c release (Fig. 11C) . We also examined the effects of RAR and VDR ligands on mitochondrial localization of RXR␣ and Nur77 and cytochrome c release in LNCaP cells treated with 3-Cl-AHPC. Unlike the inhibitory effect of RXR ligand, treatment of LNCaP cells, which express RARs and VDR, with either RAR ligand Am80 or VDR ligand had no effect on 3-Cl-AHPC-induced mitochondrial localization of RXR␣ and Nur77 and cytochrome c release (Fig. 11D) , a finding in agreement with our cotransfection results (Fig. 8) .
Consistent with their effects on cytochrome c release, 9-cis-RA and SR11237 strongly antagonized the effect of SR11453 on mitochondrial membrane potential change (Fig. 11E ) and apoptosis of LNCaP cells revealed by DAPI staining (Fig. 11F ) and the TdT assay (Fig. 11G) . Thus, 9-cis-RA inhibits cytochrome c release and apoptosis in LNCaP cells by preventing nuclear export of the RXR␣/Nur77 heterodimer.
DISCUSSION
We previously reported that Nur77 translocated from the nucleus to the cytoplasm, where it targeted mitochondria to induce apoptosis (40) . Our results presented here demonstrate that the translocation of Nur77 requires its heterodimerization with RXR␣. This is illustrated by our observations that Nur77 and RXR␣ colocalized in the cytoplasm (Fig. 1C) and that they targeted mitochondria simultaneously in LNCaP prostate cancer cells (Fig. 2) . In addition, their mitochondrial targeting depended on their coexpression (Fig. 1) . Moreover, expression of cytoplasmic RXR␣ mutant RXR␣/385 conferred cytoplasmic localization to Nur77 (Fig. 4G) , whereas overexpression of Nur77/⌬1 retained RXR␣ in the nucleus (Fig. 1G) . These results are consistent with our observation that Nur77 mitochondrial targeting and its induction of cytochrome c release and apoptosis were suppressed by RXR ligands (Fig. 11) . The translocation of the RXR␣/Nur77 heterodimer from the nucleus to mitochondria is a rapid process, occurring 1 h after cells are exposed to an apoptotic stimulus, and precedes the release of cytochrome c from mitochondria (Fig. 2) . These results agree with our previous observation (40) and are consistent with the notion that the mitochondrial targeting of RXR␣/Nur77 triggers apoptosis. Apoptosis induction by Nur77 mitochondrial targeting occurs in different types of cancer cells (10, 24, 28, 31, 37, 40, 43, 71, 79) . Our results demonstrated that RXR␣ was also required for Nur77 translocation in H460 lung cancer cells (Fig. 1H and 2C) . Thus, it is likely that RXR␣ and its ligands play a critical role in regulating Nur77-dependent apoptosis in various cancer cells.
We recently reported that Nur77 mitochondrial targeting is mediated through its interaction with Bcl-2, which mainly resides on the mitochondrial outer membrane (43) . Consistently, Nur77 mutants, such as Nur77/⌬DBD, targeted mitochondria in LNCaP cells (Fig. 6B) , which express Bcl-2, but not in HEK293T cells (Fig. 3C) , which do not. Interestingly, mitochondrial targeting by RXR␣ occurred in HEK293T cells only when both Nur77 and Bcl-2 were coexpressed (Fig. 5) , while expression of Bcl-2 alone did not result in RXR␣ mitochondrial targeting. Transfection of Nur77 mutants, but not RXR␣ mutants, into LNCaP cells targeted mitochondria and induced apoptosis (Fig. 6) . These results suggest that RXR␣ does not interact with Bcl-2 but rather functions as a shuttling protein in the Nur77-dependent apoptotic pathway. The migration of RXR␣/Nur77 heterodimers from the nucleus to the cytoplasm is CRM1 dependent. By extensive mutational analysis, we have identified an NES in the RXR␣ LBD that is required for the efficient nuclear export of RXR␣ and RXR␣/Nur77 heterodimers (Fig. 4) . A recent study suggested that NGFI-B has several NESs that are required for RXR/ NGFI-B nuclear export in PC12 cells (30) . The fact that RXR␣ also possesses an NES, which alone is capable of translocating GFP from the nucleus to the cytoplasm, offers an explanation for the efficient nuclear export of the RXR␣/Nur77 heterodimer.
One unique property of the RXR␣ NES is that it lies in helix 7 of the RXR LBD, which undergoes an unusual conformational changes upon homodimerization, homotetramerization, and heterodimerization with RAR and PPAR (5, 17, 18) . The RXR␣ helix 7 is an ␣-helix structure in the RXR␣ monomer (4). However, in the context of RXR␣ dimer, tetramer, or heterodimer with PPAR␥ or RAR, a -helix is formed due to the presence of a glutamic acid residue (E352) in the middle of helix 7 (5, 17, 18) . The transformation of helical geometry in the region, wherein the RXR␣ NES lies, suggests that RXR␣ NES activity is subject to regulation by RXR␣ homodimerization and heterodimerization. Indeed, subcellular localization of RXR␣ is highly regulated by its dimerization. This finding is clearly illustrated by our analysis of RXR␣ distribution patterns by using nondenaturing PAGE (Fig. 7C ) that shows that RXR␣/C1 existed as a monomer in the cytoplasm but in response to 9-cis-RA resided as a homodimer in the nucleus. RXR␣ mutants unable to homodimerize predominantly resided in the cytoplasm (Fig. 7D ). Heterodimerization with certain nuclear receptors, including RAR␣ and VDR, also suppressed RXR NES activity (Fig. 8) . Thus, the RXR␣ NES is active in the RXR␣ monomer but is silenced by RXR␣ homodimerization and certain heterodimerizations. Such a conformational-change-mediated regulation of RXR␣ NES activity represents a unique regulatory mechanism that dictates subcellular localization of various RXR␣ homodimers and heterodimers, ultimately allowing efficient transcriptional regulation by RXR␣ homodimers and certain RXR␣ heterodimers. Our results are consistent with previous observations that RXRs play a critical role in determining nuclear localization of TR (2) and VDR (57, 58) through their heterodimerization.
Very intriguingly, heterodimers formed by RXR␣ and VDR or RAR reside in the nucleus, whereas RXR␣/Nur77 is found in the cytoplasm when cells were treated with apoptotic stimuli (Fig. 1 ). Our results demonstrate that nuclear export of the RXR␣/Nur77 heterodimer is due to its unique heterodimer-ization in solution ( Fig. 9 and 10) . RXR possesses two dimerization interfaces, which are located in the DBD and the LBD (55, 86) . The strong dimerization interface in the LBD enables RXR homodimerization and heterodimerization with certain receptors, such as RAR and VDR in solution. In contrast, the weak dimerization interface in the DBD does not allow the formation of the RXR homodimer or heterodimer with RAR in the absence of a specific response element (60) . Our data indicate that deletion of the major dimerization interface from the RXR␣ LBD (RXR␣/385) did not impair the interaction of RXR␣ with Nur77 in solution, as revealed by an in vitro GST pull-down assay (Fig. 9A) and an in vivo coimmunoprecipitation assay (Fig. 9C) , although the deletion completely abolished RXR␣/385 interaction with RAR (Fig. 9A) . Similarly, deletion of the C-terminal sequence from Nur77 had no effect on its interaction with RXR␣ (Fig. 9B) . Our observation that the RXR␣ DBD alone was sufficient to interact with Nur77 (Fig. 9F ) demonstrated that the formation of the RXR␣/Nur77 heterodimer in solution is mediated by dimerization interfaces in their DBDs. Given the fact that the RXR␣ NES is active in the RXR␣ monomer conformation, we envision that the unique RXR␣/Nur77 heterodimer formed in solution through their DBD dimerization interfaces will ensure that the RXR␣ NES is situated in its active conformation, resulting in their nuclear export. This notion is consistent with our observation that RXR␣/385 is able to shuttle Nur77 to the cytoplasm (Fig.  4G) . Thus, the unique property of RXR dimerization interfaces allows cross talk among RXR heterodimerization partners with respect to their subcellular localization and function (Fig. 8) .
In contrast to their heterodimerization in solution, the Cterminal sequences of Nur77 and RXR␣ are required for the efficient binding of the RXR␣/Nur77 heterodimer to their specific response element ␤RARE (Fig. 10A) and transactivation (Fig. 10B) , as is found for the RXR/RAR and RXR/TR heterodimers (87) . Our observation that an RXR ligand can promote RXR␣/Nur77 heterodimer binding to the ␤RARE (Fig. 10C) is interesting since RXR ligands have not been previously shown to modulate DNA binding of other RXR heterodimers at least in vitro (87) . This finding suggests that ligand binding can modulate RXR␣/Nur77 interaction to favor DNA binding and transactivation. Such a modulation is reflected by the inhibition by 9-cis-RA of the heterodimerization of RXR␣ with Nur77/467 in solution (Fig. 10D) . Thus, the induction of RXR␣/ Nur77 heterodimer DNA binding and transactivation by 9-cis-RA is associated with its inhibition of their DBD-mediated dimerization. It is tempting to speculate that ligand binding allows RXR␣ to interact with Nur77 through their LBD dimerization interfaces, which may silence the RXR␣ NES, as does RXR/VDR or RXR/RAR heterodimerization (Fig. 8) . Thus, the nuclear export of the RXR␣/Nur77 heterodimer may be suppressed by 9-cis-RA through its induction RXR␣ homodimerization or modulation of RXR␣/Nur77 heterodimerization interfaces.
We found that RXR ligands 9-cis-RA and SR11237 effectively inhibited the release of cytochrome c induced by TPA or SR11453 in LNCaP cells (Fig. 11) . Since the inhibition was accompanied by the prevention of Nur77 and RXR␣ mitochondrial targeting (Fig. 11B) , we suggest that RXR ligands suppress apoptosis by inhibiting mitochondrial targeting of the RXR␣/Nur77 heterodimer. The inhibitory effect of RXR ligands on apoptosis has been reported previously (3, 30, 65, (81) (82) (83) . 9-cis-RA is known to potently inhibit the activationinduced apoptosis of T cells and thymocytes (3, 30, 65, (81) (82) (83) . The inhibitory effect of 9-cis-RA was enhanced in T-cell hybridomas overexpressing RXR␤ but attenuated in cells overexpressing dominant-negative RXR␤ (82) . The present study and the fact that Nur77 expression is necessary for activationinduced T-cell apoptosis suggest that inhibition of activationinduced apoptosis by RXR ligands may be mediated by their modulation of RXR␣/Nur77 heterodimer activity.
RXR␣/Nur77 nuclear export is also regulated by apoptotic stimuli. Endogenously expressed RXR␣ and Nur77 were found mainly in the nucleus (Fig. 1A) but resided in the mitochondria after cells were treated with apoptotic stimuli (Fig.  1) . How an apoptotic stimulus activates RXR␣ NES activity remains unknown. Our observations that RXR␣ and Nur77 nuclear export is highly regulated by their heterodimerization point to the possibility that the apoptotic stimulus may regulate an RXR␣/Nur77 heterodimerization interface switch. This is consistent with observations that Nur77 activities are highly regulated by phosphorylation status (9, 15, 19, 23, 49, 53, 69) and many apoptotic stimuli act through various kinase pathways. Our premise is also consistent with the recent observation that Akt, a potent antiapoptotic kinase, phosphorylates Nur77 (49, 53) . Interestingly, the location of the Akt phosphorylation site in the Nur77 C-terminal extension points to the possibility that Akt phosphorylation may modulate the interaction of Nur77 with other proteins.
Different RXR␣/Nur77 heterodimers may exist in a dynamic equilibrium depending on their cellular environment. Under normal conditions, both the DBD and the LBD dimerization interfaces may participate in RXR␣/Nur77 heterodimer formation, so that the dimers exist in both the nucleus and cytoplasm. In response to apoptotic stimuli, RXR␣ and Nur77 may preferentially heterodimerize through their DBD dimerization interfaces to activate the RXR␣ NES, resulting in their cytoplasmic localization. In contrast, binding by RXR ligands may induce a dimerization interface switch that silences the RXR␣ NES to ensure RXR␣/Nur77 nuclear localization and efficient transcriptional regulation.
Evidence has been accumulating to demonstrate that many nuclear receptors act nongenotropically to regulate important biological processes. The estrogen receptor and androgen receptor modulate the Src/Shc/Erk signaling pathway in a liganddependent manner to regulate cell proliferation. These effects can be dissociated from their transcriptional activity (32, 50) . The estrogen receptor can also act outside the nucleus to activate phosphatidylinositol-3-OH kinase activity in a liganddependent and transcriptional regulation-independent manner (64) . The results presented here demonstrate that RXR␣ also acts nongenotropically by migrating from the nucleus to mitochondria to trigger cytochrome c release and apoptosis in response to apoptotic stimuli. Thus, nongenotropic action appears to be an important mechanism by which nuclear receptors exert their biological effects. Our identification of a putative RXR␣ NES in helix 7 reveals an interesting regulatory mechanism that dictates subcellular localization of RXR␣ and its heterodimerization partners through ligands and dimerization. Our observation that RXR ligands regulate apoptosis by 
